Bolder BioTechnology's Grant

Bolder BioTechnology raised a round of funding on October 13, 2008. Investors include National Institute of Neurological Disorders and Stroke.

Bolder BioTechnology, Inc. uses advanced protein engineering technologies to create human protein pharmaceuticals with enhanced therapeutic properties. Most protein pharmaceuticals are rapidly elimina…

Articles about Bolder BioTechnology's Grant: